According to guidelines, Fertility preservation should be offered to any patient who did not accomplish his parenthood project, if the planned treatment associated with fertility reduction or loss
These conditions include oncological and non-oncological situations. Fertility preservation is safe and it is considered as important part of the quality of life of cancer survivors (1)
Building a fertility preservation program, especially in developing countries, may be challenging as it requires a legal field, a well-established cryopreservation technology, a well-established network, reimbursement system and full collaboration and awareness of Oncologists and other specialists.
In Africa, there are some examples of countries that installed a efficient fertility preservation programs but there is urgent need for a more comprehensive extension of this health offer in order to offer this procedure to African Patients (2-4)
Sharing experiences and mutual support is critical in this field
- To collect data about existing fertility preservation programs/ activities in AFRICA
- To support the creation of new FP programs in the continent
- To advocate for an affordable and accessible Fertility preservation in AFRICA
The First meeting discussing the creation of AOFC with Pr T Woodroff, Chicago November 2019
If you are already taking part of an oncofertility / fertility preservation program in you country
If you wish to start an Oncofertility/ fertility preservation program in your center or country
Please contact us
English speaking countries
Dr Chris Venter
+27 826552105
chrisv@vitalab.com
French speaking countries
Pr Mohamed KHROUF
+216 2022 1445
mkhrouf@affs-africa.org
1-ESHRE guideline: female fertility preservation.
ESHRE Guideline Group on Female Fertility Preservation,
Anderson RA, Amant F, Braat D, D'Angelo A, Chuva de Sousa Lopes SM, Demeestere I, Dwek S, Frith L, Lambertini M, Maslin C, Moura-Ramos M, Nogueira D, Rodriguez-Wallberg K, Vermeulen N. Hum Reprod Open. 2020 Nov 14;2020(4):hoaa052. doi: 10.1093/hropen/hoaa052. eCollection 2020.PMID: 33225079
2-Installing oncofertility programs for common cancers in limited resourcesettings (Repro-Can-OPEN Study):
An extrapolation during the global crisis of Coronavirus (COVID-19) pandemic.
Salama M, Ataman-Millhouse L, Braham M, Berjeb K, Khrouf M, Rodrigues JK, Reis FM, Silva TC, Sanchez F, Romero S, Smitz J, Vasquez L, Vega M, Sobral F, Terrado G, Lombardi MG, Scarella A, Bourlon MT, Verduzco-Aguirre H, Sanchez AM, Adiga SK, Tholeti P, Udupa KS, Mahajan N, Patil M, Dalvi R, Venter C, Demetriou G, Geel J, Quintana R, Rodriguez G, Quintana T, Viale L, Fraguglia M, Coirini M, Remolina-Bonilla YA, Noguera JAR, Velasquez JC, Suarez A, Arango GD, Pineda JID, Aldecoa MDC, Javed M, Al Sufyan H, Daniels N, Oranye BC, Ogunmokun AA, Onwuzurigbo KI, Okereke CJ, Whesu TC, Woodruff TK .J Assist Reprod Genet. 2020 Jul;37(7):1567-1577. doi: 10.1007/s10815-020-01821-7. Epub 2020 Jun 27.
3-Building Oncofertility Core Competency in Developing Countries: Experience From Egypt, Tunisia, Brazil, Peru, and Panama.
Salama M, Ataman L, Taha T, Azmy O, Braham M, Douik F, Khrouf M, Rodrigues JK, Reis FM, Sanchez F, Romero S, Vega M, Woodruff TK. JCO Glob Oncol. 2020 Mar 2;6:JGO.17.00121. doi: 10.1200/JGO.17.00121. eCollection 2020.PMID: 32259156
4-Building Oncofertility Core Competency in Developing Countries:
Experience From Egypt, Tunisia, Brazil, Peru, and Panama.
Salama M, Ataman L, Taha T, Azmy O, Braham M, Douik F, Khrouf M, Rodrigues JK, Reis FM, Sanchez F, Romero S, Vega M, Woodruff TK. J Glob Oncol. 2018 Sep;4:1-11. doi: 10.1200/JGO.17.00121.
